Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion description "[These findings suggest that dual-targeting TAK1 and c-Myc might be a rational therapeutic strategy for treatment of certain types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion evidence source_evidence_literature NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion SIO_000772 23523871 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion wasDerivedFrom befree-20140225 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion wasGeneratedBy ECO_0000203 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.